Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma
-
Global Electronics Association Debuts; New Name Elevates IPC’s 70-Year Legacy as Voice of $6 Trillion Electronics Industry
-
ZA Miner Unveils 2025 Dogecoin & Ethereum Cloud Mining Event
-
ZA Miner Unveils 2025 Dogecoin & Ethereum Cloud Mining Event
-
Shareholders who own 3D Systems (NYSE: DDD) Should Contact Wolf Haldenstein
-
McLaren Health Care Data Breach Alert Issued By Wolf Haldenstein
-
PFMCrypto Launches Revolutionary XRP Mining Contracts, Igniting Market Enthusiasm
-
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
-
Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
-
Bitget Partners with MotoGP for a High-Speed Collision of Tech and Speed
-
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
-
Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows
-
Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift
-
Jason Yang and Ruoqi Li Featured In XYZ Media’s “Next Generation of Innovators” Series for Developing an AI-Driven Multimodal Model Advancing Elderly Fall Risk Assessment
-
Jacob Wang Featured in XYZ Media’s “Next Generation of Innovators” for Developing a Self-Actuated, Eco-Friendly Soft Robot for Drug Delivery
-
BTC News: Bitcoin Solaris Presale Enters Final Phase Ahead of Mainnet Launch
-
Key Home Goods Unveils Limited Edition Cutting Board Collection: Where Functional Art Meets Heritage Craftsmanship
-
BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions
-
Can’t Wait for XRP to Hit $10? PFMCrypto Launches 1-Day Cloud Mining Contract With $10 Free Bonus
-
ZA Miner Launches Free Cloud Mining App Amid Rising Crypto Adoption in 2025
-
XRP Struggles to Break $3 Barrier, While PFMCrypto Launches Innovative XRP Cloud Mining Contracts to Widespread Interest
-
XRP News: Vaultro Finance Presale on XRP Is Set to End in 7 Days, Already Sold Out 72% of Its Allocation — Join $VLT Presale Now
-
Trump, Munir exchange praises as Pakistan rises as regional stabilizer: IRS Analysis
-
Canadian North Resources Announces Results of 2025 Annual and Special Meeting of Shareholders
-
Abvance Therapeutics Announces Presentation of Human Clinical Data at the 85th Scientific Sessions of the American Diabetes Association
-
Debt Consolidation Loan for Poor Credit Score: Radcred Instant Funding Solution with No Credit Check & Same-Day Loan
-
Kaanch Network Presale Positions Project Among Top Altcoins and Best Crypto Opportunities of 2025
-
OCUFA Challenges Ontario Government's Narrative on Postsecondary Funding Crisis, Welcomes Review with Call for Meaningful Faculty Consultation
-
BexBack Launches $50 Welcome Bonus and 100% Deposit Match to Empower Crypto Traders with 100x Leverage
-
Martini Market Presale Surpasses 40% of Softcap Within 24 Hours of Launch on XRP Ledger
-
Wilson Blanchard Management Raises $169,000 at 2025 WB CondoCon in Support of Associa Cares Canada
-
XRP News: Vaultro Finance Presale on XRP Sells Over 70% of Allocation – Only 30% Now Remaining for Early Investors to Participate
-
AIXA Miner Unveils New Free Cloud Mining Platform Aligned with 2025 Green Tech and Smart Mining Goals
-
Government of Pakistan Recommends President Donald J. Trump for 2026 Nobel Peace Prize
-
1000 MIGLIA 2025, the fifth and final leg has started
-
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting
-
Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical Trial
-
Bitcoin Solaris Announces Final Presale Phase Ahead of July Launch
-
ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients
-
Certified and Profitable: AIXA Miner Redefines Passive Crypto Income After FinCEN Approval
-
Jetoptera Executes FETT for FTC-250 at Paris Air Show 2025
-
Nomad Internet Launches First-Ever Nationwide Free Internet Service for RV Parks
-
MountBay Energy Unlocks Microbial Biofilm Technology to Revolutionize Battery Longevity
-
The China Fund, Inc. Announces Board Approval of Plan of Liquidation
-
Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration
-
Jane Silverstone Segal Increases Number of Shares of DAVIDsTEA Inc. Under Her Control
-
Enzon and Viskase Enter into Merger Agreement
-
Global AI Spotlight: DataGlobal Hub Assembles Hundreds of Industry Leaders for GDAI 2025, The Largest Global Virtual AI & Data Conference
-
Novo Nordisk: Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA
-
Novo Nordisk’s subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
